Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)

Taiwan · Delayed Price · Currency is TWD

10.05

-0.05 (-0.50%)

Jul 14, 2026, 1:19 PM CST

-7.37% (1Y)

Market Cap	904.50M -21.8%
Revenue (ttm)	364.79M +3.0%
Net Income	28.05M +22.6%
EPS	0.31 +24.0%
Shares Out	90.00M
PE Ratio	32.42
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	76,088
Open	10.10
Previous Close	10.10
Day's Range	9.82 - 10.15
52-Week Range	9.12 - 17.65
Beta	0.36
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About TPEX:4186

Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA and rapid test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers stem cell banking services for newborn and adult stem cells storage; cell therapy programs; abused drugs rapid tests... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1989

Employees 160

Stock Exchange Taipei Exchange

Ticker Symbol 4186

Full Company Profile

Financial Performance

In 2025, TPEX:4186's revenue was 364.79 million, an increase of 3.00% compared to the previous year's 354.17 million. Earnings were 28.05 million, an increase of 22.61%.

Financial Statements